NP101

DRUG3 trials

Sponsors

NuPathe Inc.

Conditions

Compare Bioequivalence Patches Previously Used in the NP101-007 StudyMigraine Disorders

Phase 1

Compare PK and Bioavailability of 2 NP101 Patches With Oral Imitrex in Healthy Adults

CompletedNCT01381796

NuPathe Inc.Compare Bioequivalence Patches Previously Used in the NP101-007 Study

Start: 2009-12-31End: 2010-09-30Updated: 2017-10-12

Phase 3

An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months

CompletedNCT00792103

NuPathe Inc.Migraine Disorders

Start: 2009-01-31End: 2010-09-30Updated: 2016-02-04

An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months

CompletedNCT00806546

NuPathe Inc.Migraine Disorders

Start: 2009-02-28End: 2011-05-31Updated: 2016-02-04